A5011582408- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Nausea and vomiting management
- Metastasis and carcinoma case studies
- Palliative Care and End-of-Life Issues
- Anesthesia and Pain Management
- Pathogenesis and Treatment of Hiccups
- Patient Dignity and Privacy
- Lung Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Head and Neck Surgical Oncology
- Neuroendocrine Tumor Research Advances
- Trauma Management and Diagnosis
- Oral and Maxillofacial Pathology
- Cardiovascular Syncope and Autonomic Disorders
- Gastrointestinal Tumor Research and Treatment
- Salivary Gland Tumors Diagnosis and Treatment
- Tumors and Oncological Cases
- Respiratory and Cough-Related Research
- Pleural and Pulmonary Diseases
- Cancer therapeutics and mechanisms
- Colorectal and Anal Carcinomas
- Cardiac Arrhythmias and Treatments
- Oral health in cancer treatment
Korean Cancer Association
2019
St. Vincent's Hospital
2007-2018
Catholic University of Korea
2010-2015
St Vincent's Hospital
2014
Saint Vincent's Catholic Medical Center
2014
St. Vincent's Birmingham
2014
Suwon Catholic University
2007
This randomized phase III study was designed to compare the efficacy and safety of irinote-can plus cisplatin (IP) over etoposide (EP) in Korean patients with extensive-disease small-cell lung cancer (SCLC).Patients were randomly assigned receive IP, composed irinotecan 65 mg/m2 intravenously on days 1 8+cisplatin 70 day every 3 weeks, or EP, 100 1, 2, 3+cisplatin weeks for a maximum six cycles, until disease progression, unacceptable toxicity occurred. The primary endpoint overall...
In Korea, most terminal cancer patients have still not been included in end-of-life (EOL) discussions. The purpose of this study was to evaluate the proportion participating EOL discussions after adopting advance directives.Medical records 106 hospice between July 2012 and February 2013 were reviewed retrospectively. patient participation discussions, barriers, favorable factors for completion directives, as well outcomes directives evaluated.Patient discussion had increased from 16/53 (30%)...
Experience of Advance Directives in a Hospice CenterTo protect patient autonomy when confronting death, the importance advance directives (ADs) has recently became an issue and gradually accepted Korea.However, real practice, ADs were not completed by patients but their families most cases.To analyze current situation performing ADs, we reviewed medical charts 214 terminal cancer admitted to hospice center from October 2012 September 2013.Seventy-six (35.5%) ADs.All themselves.The common...
We report a surgical case of primary polymorphous low-grade adenocarcinoma (PLGA) the minor salivary gland-type lung. A PLGA originating from right upper lobar bronchial inlet was successfully treated by sleeve lobectomy. PLGAs are thought to be indolent tumors that preferentially localized palate, and they affect glands almost exclusively. Until now, two cases distant metastases lung have been reported in English literature. To best our knowledge, only one without evidence previous...
The aim of this study was to determine the expressions Rb, p16, and cyclin D1 in soft tissue sarcomas, we also wanted identify prognostic factors according clinicalpathologic features.We reviewed charts radiographic films 66 sarcoma patients. Tissue samples were collected from these Immunochemistry performed using formalin-fixed, paraffin-embedded examine proteins.The median duration overall survival 47.8 months (range, 20.0 70.7 months) 5 years rate 39%. As for correlation between degree...
This study was conducted to evaluate the efficacy and safety of azasetron compared ondansetron in prevention delayed chemotherapy-induced nausea vomiting.This a multi-center, prospective, randomized, double-dummy, double-blind parallel-group trial involving 12 institutions Korea between May 2005 December 2005. A total 265 patients with moderately highly emetogenic chemotherapy were included randomly assigned either or group. All received (10 mg intravenously) dexamethasone (20 on day 1 (4...
Diarrhea is a common adverse event of docetaxel with 20%-40% incidence and severe diarrhea occurs in 5%-6%. Several treatment guidelines for chemotherapy induced (CID) exist, however the prophylaxis that not well known. We describe new prophylactic approach CID loperamide. A 72-yr-old male patient stage IV non-small-cell lung cancer developed repeatedly after docetaxel-cisplatin chemotherapy. His persisted despite including loperamide fasting. However, was successfully prevented when given...
Primary small cell carcinoma of the paranasal sinuses is extremely rare. It aggressively locally invasive, with high recurrence and metastatic rates. A combination systemic chemotherapy locoregional treatment, such as radiotherapy, currently recommended based on treatment lung. We report a case originating from maxillary sinus distant metastasis at time diagnosis. The patient had good initial therapeutic response to etoposide-cisplatin chemotherapy, but cancer progressed after sixth cycle...
Cough syncope is characterized by the loss of consciousness occurring after vigorous coughings.There are approximately 90 reported cases cough within medical literature.Most involving middle aged, overweight and chronic bronchitic male smokers.Although many studies have been published in literature, mechanism pathophysiology for has not well established.Cough treated correcting underlying cause when identified, or avoiding conditions that may syncope.In addition, suppression modalities can...
Talc pleurodesis is a safe and effective treatment for recurrent malignant pleural effusion. However, acute hypoxemia, pulmonary edema or respiratory failure can develop in small number of patients. We report 2 patients who developed fatal hypoxemia after talc which was necessary the control The first case an 18-year old male diagnosed with Ewing's sarcoma bilateral lung metastases performance status ECOG (Eastern Cooperative Foncology Group) grade 3. Fever along leukocytosis 10 hours second...
Dr. Hong was born in